ESMO Honours Outstanding Oncology Professionals - CBS 5 - KPHO

ESMO Honours Outstanding Oncology Professionals

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE European Society for Medical Oncology (ESMO)

LUGANO, Switzerland, August 22, 2014 /PRNewswire/ --

The European Society for Medical Oncology (ESMO), the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid.

Carsten Bokemeyer will receive the ESMO Award  for his commitment to accelerate the transition of cancer discovery into real benefit for patients

A world leader in the pathogenesis and biology of malignant germ cell tumours, Bokemeyer is Director of the University Cancer Center Hamburg, one of Germany's oncology centres of excellence. Bokemeyer's discoveries include identifying the early stages of malignant germ cell transformation and the mechanisms of resistance of these tumours to chemotherapy. He has also developed new therapeutic concepts with cytostatic drugs and immunotherapy in solid tumours.

Peter Boyle wins the ESMO Lifetime Achievement Award  for his long-standing contribution to cancer epidemiology, education and prevention

Professor of Global Public Health at the University of Strathclyde, Honorary or Visiting Professor at Glasgow and Yale Universities, Boyle is founder and President of the World Prevention Alliance. He led the EUROCAN+PLUS project for the European Parliament to develop priorities for cancer research in Europe and was Editor of the World Cancer Report 2008 and the State of Oncology 2013, highlighting the growing global cancer crisis.

Heikki Joensuu acknowledged with the Hamilton Fairley Award  for his significant contribution to improve breast cancer and GIST diagnostics and care

Internationally known for his clinical and translational research, in 2000 Joensuu discovered that imatinib was effective for most advanced GIST and in 2011 found that as adjuvant treatment it improved recurrence-free survival and possibly overall survival. Joensuu became Professor of Oncology at the age of 37 and is currently Academy Professor at the University of Helsinki and Research Director at the Helsinki Comprehensive Cancer Centre.

Full story: http://www.esmo.org/Press-Office/Press-Releases/ESMO-Honours-Outstanding-Oncology-Professionals

About ESMO 

ESMO is the leading European professional organisation committed to advancing the specialty of medical oncology to advance cancer care and cure. http://www.esmo.org

Media contact
media@esmo.org
+41-91-973-19-07

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
CBS 5
Powered by WorldNow CNN
All content © 2014, CBS 5 (KPHO Broadcasting Corporation), Phoenix, AZ and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service..